Search

everythinglearnresearchcommunity

for

Search:↓

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

IL-18 signaling helps mature Tregs move into the thymus.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

IL-18 signaling helps mature Tregs move into the thymus.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

IL-13 protein is much higher in the skin of atopic dermatitis patients than in healthy skin.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Blocking IL-8 can reduce skin rashes from cancer treatment.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Ustekinumab treatment may reveal a genetic tendency for steatocystoma multiplex in psoriasis patients.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.